Your browser doesn't support javascript.
loading
Difficult-to-Treat Concept in Psoriatic Arthritis: Analysis of 2 Potential Definitions in a Large Group of Patients: A Cross-Sectional Study.
Perrotta, Fabio Massimo; Gentileschi, Stefano; Scriffignano, Silvia; Terribili, Riccardo; Bianchi, Elena; Frediani, Bruno; Lubrano, Ennio.
Afiliación
  • Perrotta FM; F.M. Perrotta, MD, PhD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso.
  • Gentileschi S; S. Gentileschi, MD, Rheumatology Unit, Dipartimento di Medicina, Chirurgia e Neuroscienze, Università degli Studi di Siena, Siena, Italy.
  • Scriffignano S; S. Scriffignano, MD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso.
  • Terribili R; R. Terribili, MD, Rheumatology Unit, Dipartimento di Medicina, Chirurgia e Neuroscienze, Università degli Studi di Siena, Siena, Italy.
  • Bianchi E; E. Bianchi, MD, Rheumatology Unit, Dipartimento di Medicina, Chirurgia e Neuroscienze, Università degli Studi di Siena, Siena, Italy.
  • Frediani B; B. Frediani, MD, Rheumatology Unit, Dipartimento di Medicina, Chirurgia e Neuroscienze, Università degli Studi di Siena, Siena, Italy.
  • Lubrano E; E. Lubrano, MD, PhD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso.
J Rheumatol ; 2024 Aug 01.
Article en En | MEDLINE | ID: mdl-39009395
ABSTRACT

OBJECTIVE:

The main aim of the study was to evaluate the performance of 2 proposed criteria for difficult-to-treat (D2T) psoriatic arthritis (PsA) in a group of patients and to evaluate the agreement between the 2 sets of criteria.

METHODS:

We performed a cross-sectional analysis of 2 longitudinal cohorts of patients with PsA fulfilling the Classification Criteria for Psoriatic Arthritis (CASPAR), with at least 1 year of follow-up. A detailed medical history was collected and a physical examination was performed for all recruited patients. The proposed criteria for patients with D2T PsA were applied in our group. To test the performance of the 2 sets of criteria, we used an external validator (absence of patient acceptable symptom state + physician global assessment ≥ 6 cm). Finally, the agreement between the 2 sets of criteria was assessed.

RESULTS:

We evaluated 378 patients with PsA (219 male/159 female), with a mean age (range) of 58 (19-75) years. Seventy-five (19.8%) patients fulfilled the D2T criteria proposed by Perrotta et al and 58 (15.3%) the D2T criteria proposed by Kumthekar et al. Both criteria showed comparable performance, with low sensitivity (Perrotta 37.8%, Kumthekar 29.7%) but good specificity (Perrotta 82.1%, Kumthekar 86.2%). Finally, the agreement between the 2 sets of criteria is substantial (Fleiss κ 0.72), suggesting that both criteria identify nearly the same group of patients.

CONCLUSION:

Our study compared 2 published sets of criteria showing comparable performance and substantial agreement. This study may pave the way for further research in this field.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Rheumatol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Rheumatol Año: 2024 Tipo del documento: Article